Miltenyi Biotec
Miltenyi Biotec home - back to start page
Miltenyi BiotecMiltenyi Biotec
Miltenyi Biotec
Miltenyi Biotec
Miltenyi Biotec
navigation Sample preparation
navigation Cell separation
navigation Cell analysis
navigation Cell culture
navigation Molecular applications
Miltenyi Biotec
Miltenyi Links
Miltenyi Home
MACS Cytokines
MACS Cell Analysis
Tissue Dissociation
Neuroscience
Genomic Services
Miltenyi Biotec
Anti-Fibroblast MicroBeads
Description
Anti-Fibroblast MicroBeads have been developed for the positive selection or depletion of human fibroblasts using a fibroblast-specific antigen.1 This antigen is also known to be expressed on mesenchymal stromal cells (MSCs) in the bone marrow.2–4
Applications
Applications of the Anti-Fibroblast MicroBeads include the isolation of MSCs from bone marrow aspirate or the removal of fibroblastic cells from bone marrow cultures or other primary tissue cultures. The depletion of fibroblast cells can be an effective step in the establishment of primary tumor cell lines in order to prevent fibroblastic overgrowth within the tissue culture.
Furthermore, human fibroblasts that are used as feeder cells to support the growth of ES or iPS cells can be depleted by using the Anti-Fibroblast MicroBeads.
Columns
For positive selection: MS, LS, XS, or autoMACS® Columns.
For depletion: LD, CS, D, or autoMACS Columns.
 
Figure 1
Fibroblast antigen–positive cells were isolated from bone marrow mononuclear cells (BM-MNCs) using the Anti-Fibroblast MicroBeads, an MS Column, and a MiniMACS™ Separator. Cells were stained with CD271 (LNGFR)-PE and CD45-FITC. (Courtesy of Dr. Elena Jones, Leeds, UK.)
BM-MNCs before separation
Fibroblast antigen cells
Fibroblast antigen+ cells
Miltenyi Biotec
Search this website
Services
Customer login
Contact
Newsletter
Favorites / Prices
Request prices or add products to your favorite list.
Details
Products
Anti-Fibroblast MicroBeads, human
- for 109 total cells
Download datasheet
130-050-601
Qty.:
 

Related products
Pre-Separation Filters, 30 µm (#130-041-407)
References
1. Fearns and Dowdle (1992) Int. J. Cancer 50: 621–627.
2. Jones et al. (2002) Arthritis and Rheumatism 46: 3349–3360.
3. Jones et al. (2006) Cytometry B: Clin. Cytom. 70: 391–399.
4. Jones et al. (2007) MACS&more 11-1: 22–25.
MACS Stem Cell newsletter
Stay current with important developments in stem cell research by subscribing to Stem Cell Updates.
 
 
 
 
 
 
 
© 1999 - 2012 Miltenyi Biotec ¦ Terms & conditions ¦ Legal notes
Miltenyi Biotec website